KUALA LUMPUR, Aug 7 -- Kirin Holdings Company Limited has announced that five of its products (three soft drinks and two supplements) that utilise Lactococcus lactis strain Plasma are registered as Foods with Function Claims with Japan’s Consumer Affairs Agency (CAA).
According to a statement, this is the first time that an immune system-related product has been registered in Japan.
When registration is accepted by the CAA, labeling of ‘function claims’ (usually health benefits) on products becomes possible. This registration provides the value of reliability and reassurance for consumers when choosing products.
The Kirin Group Vision 2027 sets out the broad goal of creating value worldwide of food & beverages to pharmaceuticals.
To augment the Group’s existing Food & Beverages domain and Pharmaceuticals domain, it has launched a new Health Science domain to help people stay fit and healthy by leveraging advanced fermentation and biotechnology the Group has amassed over the years.
One example of this is leveraging the Group’s 35 years of research that led to the development of Lactococcus lactis strain Plasma, jointly developed across Group companies.
Moving forward, Kirin Group will accelerate domestic sales as well as expand overseas sales of products that utilise Lactococcus lactis strain Plasma, leading to further contribution to the health and well-being of the global community.
The Lactococcus lactis strain Plasma is a type strain of Lactococcus lactis, a natural lactic acid bacterium mainly used for the fermentation of cheese and yogurt.
More details at www.kirinholdings.co.jp/english/
-- BERNAMA
No comments:
Post a Comment